Page last updated: 2024-08-16

mitomycin and theophylline

mitomycin has been researched along with theophylline in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19903 (42.86)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Aoyama, T; Kimura, H; Otsu, Y1
Besana, C; Ferrero, E; Ferrero, ME; Gromo, G; Pardi, R; Rugarli, C; Zocchi, MR1
Fujii, T; Hanada, S; Nakatsuka, T1
de las Alas, MM; Doria, M; Gaginella, TS; Kachur, JF; Keshavarzian, A; Sundaresan, R; Walsh, R1

Reviews

1 review(s) available for mitomycin and theophylline

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

6 other study(ies) available for mitomycin and theophylline

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Methylisobutylxanthine, a potent inhibitor of cAMP phosphodiesterase, enhances the sensitivity of Chinese hamster ovary cells to mitomycin C.
    Chemico-biological interactions, 1987, Volume: 64, Issue:1-2

    Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Bucladesine; Cell Survival; Cells, Cultured; Cricetinae; Dose-Response Relationship, Drug; Interphase; Mitomycin; Mitomycins; Theophylline

1987
Theophylline induced non specific suppressor activity in human peripheral blood lymphocytes.
    Journal of immunopharmacology, 1985, Volume: 7, Issue:2

    Topics: Adult; Cells, Cultured; Concanavalin A; Cyclic AMP; Humans; Lymphocyte Activation; Mitomycin; Mitomycins; Phytohemagglutinins; Rosette Formation; T-Lymphocytes, Regulatory; Theophylline

1985
Potentiating effects of methylxanthines on teratogenicity of mitomycin C in mice.
    Teratology, 1983, Volume: 28, Issue:2

    Topics: Abnormalities, Drug-Induced; Animals; Antibiotics, Antineoplastic; Caffeine; Drug Synergism; Female; Mice; Mice, Inbred ICR; Mitomycin; Mitomycins; Pregnancy; Structure-Activity Relationship; Theobromine; Theophylline; Xanthines

1983
Colitis reduces short-circuit current response to inflammatory mediators in rat colonic mucosa.
    Inflammation, 1995, Volume: 19, Issue:2

    Topics: Alprostadil; Animals; Anions; Bradykinin; Carbachol; Colitis; Intestinal Mucosa; Male; Mitomycin; Neutrophils; Patch-Clamp Techniques; Peroxidase; Rats; Rats, Sprague-Dawley; Second Messenger Systems; Secretory Rate; Serotonin; Substance P; Theophylline; Time Factors

1995